Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia-Reference-Cited by-同舟云学术

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia

Published:2019-08 Issue:2 Volume:71 Page:281-288
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Alavi Maryam^ORCID,Law Matthew G.,Valerio Heather,Grebely Jason^ORCID,Amin Janaki,Hajarizadeh Behzad^ORCID,Selvey Christine,George Jacob,Dore Gregory J.

Funder

Australian Government Department of Health

New South Wales Ministry of Health

Cancer Council New South Wales

National Health and Medical Research Council

Australia Career Development Fellowship

Sydney West Translational Cancer Research Centre

Cancer Institute New South Wales

Publisher

Elsevier BV

Subject

Hepatology

Reference31 articles.

1. Hepatitis C virus therapeutic development: in pursuit of “perfectovir”;Dore;Clin Infect Dis,2015

2. World Health Organization. Global health sector strategy on viral hepatitis 2016-2021 2016 [June 2018]. Available from: www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.

3. Oral Direct-acting agent therapy for hepatitis c virus infection: a systematic review;Falade-Nwulia;Ann Intern Med,2017

4. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;van der Meer;JAMA,2012

5. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis;Veldt;Ann Intern Med,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition;2024-01-30

2. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?;Expert Review of Molecular Diagnostics;2024-01-04

3. Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care;Journal of Gastroenterology and Hepatology;2023-12-19

4. Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia;Internal Medicine Journal;2023-10-11

5. A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data;Addiction;2023-09-19